nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethionamide—Salivary hypersecretion—Pentoxifylline—systemic scleroderma	0.0169	0.0169	CcSEcCtD
Ethionamide—Digestion impaired—Leflunomide—systemic scleroderma	0.0162	0.0162	CcSEcCtD
Ethionamide—Hypothyroidism—Mycophenolic acid—systemic scleroderma	0.0161	0.0161	CcSEcCtD
Ethionamide—Taste metallic—Methotrexate—systemic scleroderma	0.0145	0.0145	CcSEcCtD
Ethionamide—Neuritis—Leflunomide—systemic scleroderma	0.0145	0.0145	CcSEcCtD
Ethionamide—Vascular purpura—Pentoxifylline—systemic scleroderma	0.0141	0.0141	CcSEcCtD
Ethionamide—Purpura—Pentoxifylline—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Ethionamide—Hypothyroidism—Mycophenolate mofetil—systemic scleroderma	0.0127	0.0127	CcSEcCtD
Ethionamide—Neurotoxicity—Methotrexate—systemic scleroderma	0.0119	0.0119	CcSEcCtD
Ethionamide—Gynaecomastia—Captopril—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Ethionamide—Photosensitivity—Captopril—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Ethionamide—Drowsiness—Pentoxifylline—systemic scleroderma	0.00971	0.00971	CcSEcCtD
Ethionamide—Jaundice—Pentoxifylline—systemic scleroderma	0.00947	0.00947	CcSEcCtD
Ethionamide—Salivary hypersecretion—Lisinopril—systemic scleroderma	0.00905	0.00905	CcSEcCtD
Ethionamide—Optic neuritis—Prednisone—systemic scleroderma	0.009	0.009	CcSEcCtD
Ethionamide—Orthostatic hypotension—Captopril—systemic scleroderma	0.00872	0.00872	CcSEcCtD
Ethionamide—Hepatitis—Pentoxifylline—systemic scleroderma	0.00872	0.00872	CcSEcCtD
Ethionamide—Hypothyroidism—Prednisone—systemic scleroderma	0.00862	0.00862	CcSEcCtD
Ethionamide—Photosensitivity—Lisinopril—systemic scleroderma	0.0077	0.0077	CcSEcCtD
Ethionamide—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.0077	0.0077	CcSEcCtD
Ethionamide—Erectile dysfunction—Captopril—systemic scleroderma	0.0076	0.0076	CcSEcCtD
Ethionamide—Photosensitivity reaction—Captopril—systemic scleroderma	0.00754	0.00754	CcSEcCtD
Ethionamide—Weight decreased—Captopril—systemic scleroderma	0.00747	0.00747	CcSEcCtD
Ethionamide—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00743	0.00743	CcSEcCtD
Ethionamide—Neuritis—Prednisone—systemic scleroderma	0.00741	0.00741	CcSEcCtD
Ethionamide—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00734	0.00734	CcSEcCtD
Ethionamide—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.00731	0.00731	CcSEcCtD
Ethionamide—Stomatitis—Captopril—systemic scleroderma	0.00718	0.00718	CcSEcCtD
Ethionamide—Jaundice—Captopril—systemic scleroderma	0.00718	0.00718	CcSEcCtD
Ethionamide—Vision blurred—Pentoxifylline—systemic scleroderma	0.00715	0.00715	CcSEcCtD
Ethionamide—Agitation—Pentoxifylline—systemic scleroderma	0.00698	0.00698	CcSEcCtD
Ethionamide—Hypoglycaemia—Lisinopril—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Ethionamide—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00686	0.00686	CcSEcCtD
Ethionamide—Diplopia—Lisinopril—systemic scleroderma	0.00677	0.00677	CcSEcCtD
Ethionamide—Hepatitis—Captopril—systemic scleroderma	0.00661	0.00661	CcSEcCtD
Ethionamide—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00618	0.00618	CcSEcCtD
Ethionamide—Weight decreased—Leflunomide—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Ethionamide—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00607	0.00607	CcSEcCtD
Ethionamide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00607	0.00607	CcSEcCtD
Ethionamide—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.00598	0.00598	CcSEcCtD
Ethionamide—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.00595	0.00595	CcSEcCtD
Ethionamide—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Ethionamide—Jaundice—Leflunomide—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Ethionamide—Stomatitis—Leflunomide—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Ethionamide—Anorexia—Pentoxifylline—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Ethionamide—Weight decreased—Mycophenolic acid—systemic scleroderma	0.00587	0.00587	CcSEcCtD
Ethionamide—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00579	0.00579	CcSEcCtD
Ethionamide—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00567	0.00567	CcSEcCtD
Ethionamide—Jaundice—Mycophenolic acid—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Ethionamide—Stomatitis—Mycophenolic acid—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Ethionamide—Dysgeusia—Captopril—systemic scleroderma	0.00563	0.00563	CcSEcCtD
Ethionamide—Somnolence—Pentoxifylline—systemic scleroderma	0.00551	0.00551	CcSEcCtD
Ethionamide—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Ethionamide—Hepatitis—Leflunomide—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Ethionamide—Vision blurred—Captopril—systemic scleroderma	0.00542	0.00542	CcSEcCtD
Ethionamide—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00541	0.00541	CcSEcCtD
Ethionamide—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Ethionamide—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Ethionamide—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Ethionamide—Weight decreased—Lisinopril—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Ethionamide—Depression—Lisinopril—systemic scleroderma	0.0052	0.0052	CcSEcCtD
Ethionamide—Hepatitis—Mycophenolic acid—systemic scleroderma	0.0052	0.0052	CcSEcCtD
Ethionamide—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Ethionamide—Anorexia—Mometasone—systemic scleroderma	0.0051	0.0051	CcSEcCtD
Ethionamide—Jaundice—Lisinopril—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Ethionamide—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Ethionamide—Abdominal pain—Pentoxifylline—systemic scleroderma	0.0049	0.0049	CcSEcCtD
Ethionamide—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00472	0.00472	CcSEcCtD
Ethionamide—Dyspepsia—Mometasone—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Ethionamide—Hepatitis—Lisinopril—systemic scleroderma	0.00468	0.00468	CcSEcCtD
Ethionamide—Decreased appetite—Mometasone—systemic scleroderma	0.00465	0.00465	CcSEcCtD
Ethionamide—Dysgeusia—Leflunomide—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Ethionamide—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Ethionamide—Thrombocytopenia—Captopril—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Ethionamide—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00456	0.00456	CcSEcCtD
Ethionamide—Depression—Mycophenolate mofetil—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Ethionamide—Vascular purpura—Prednisone—systemic scleroderma	0.00449	0.00449	CcSEcCtD
Ethionamide—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Ethionamide—Anorexia—Captopril—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Ethionamide—Vision blurred—Leflunomide—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Ethionamide—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Ethionamide—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Ethionamide—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Ethionamide—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Ethionamide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Ethionamide—Abdominal pain—Mometasone—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Ethionamide—Somnolence—Captopril—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Ethionamide—Purpura—Prednisone—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Ethionamide—Agitation—Mycophenolic acid—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Ethionamide—Gynaecomastia—Methotrexate—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Ethionamide—Dyspepsia—Captopril—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Ethionamide—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Ethionamide—Dizziness—Pentoxifylline—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Ethionamide—Decreased appetite—Captopril—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Ethionamide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Ethionamide—Dysgeusia—Lisinopril—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Ethionamide—Vomiting—Pentoxifylline—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Ethionamide—Psychotic disorder—Prednisone—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Ethionamide—Rash—Pentoxifylline—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Ethionamide—Dermatitis—Pentoxifylline—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Ethionamide—Headache—Pentoxifylline—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Ethionamide—Vision blurred—Lisinopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Ethionamide—Gastrointestinal pain—Captopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Ethionamide—Photosensitivity—Methotrexate—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Ethionamide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Ethionamide—Abdominal pain—Captopril—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Ethionamide—Anorexia—Leflunomide—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Ethionamide—Nausea—Pentoxifylline—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Ethionamide—Diarrhoea—Mometasone—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Ethionamide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Ethionamide—Anorexia—Mycophenolic acid—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Ethionamide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Ethionamide—Dyspepsia—Leflunomide—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Ethionamide—Vomiting—Mometasone—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Ethionamide—Rash—Mometasone—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Ethionamide—Dermatitis—Mometasone—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Ethionamide—Decreased appetite—Leflunomide—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Ethionamide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Ethionamide—Headache—Mometasone—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Ethionamide—Somnolence—Mycophenolic acid—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Ethionamide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Ethionamide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Ethionamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Ethionamide—Abdominal pain—Azathioprine—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Ethionamide—Diarrhoea—Captopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Ethionamide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Ethionamide—Erectile dysfunction—Prednisone—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Ethionamide—Nausea—Mometasone—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Ethionamide—Anorexia—Lisinopril—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Ethionamide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Ethionamide—Weight decreased—Prednisone—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Ethionamide—Dizziness—Captopril—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Ethionamide—Depression—Prednisone—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Ethionamide—Abdominal pain—Leflunomide—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Ethionamide—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Ethionamide—Hypersensitivity—Azathioprine—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Ethionamide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Ethionamide—Vomiting—Captopril—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Ethionamide—Rash—Captopril—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Ethionamide—Dermatitis—Captopril—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Ethionamide—Somnolence—Lisinopril—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Ethionamide—Headache—Captopril—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Ethionamide—Dyspepsia—Lisinopril—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Ethionamide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Ethionamide—Decreased appetite—Lisinopril—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Ethionamide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Ethionamide—Hypersensitivity—Leflunomide—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Ethionamide—Diarrhoea—Azathioprine—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Ethionamide—Nausea—Captopril—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Ethionamide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Ethionamide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Ethionamide—Dizziness—Azathioprine—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Ethionamide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Ethionamide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Ethionamide—Diarrhoea—Leflunomide—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Ethionamide—Abdominal pain—Lisinopril—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Ethionamide—Vomiting—Azathioprine—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Ethionamide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Ethionamide—Drowsiness—Methotrexate—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Ethionamide—Rash—Azathioprine—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Ethionamide—Dermatitis—Azathioprine—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Ethionamide—Depression—Methotrexate—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Ethionamide—Headache—Azathioprine—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Ethionamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Ethionamide—Dizziness—Leflunomide—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Ethionamide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Ethionamide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Ethionamide—Stomatitis—Methotrexate—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Ethionamide—Vomiting—Leflunomide—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Ethionamide—Hypersensitivity—Lisinopril—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Ethionamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Ethionamide—Rash—Leflunomide—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Ethionamide—Dermatitis—Leflunomide—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Ethionamide—Nausea—Azathioprine—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Ethionamide—Headache—Leflunomide—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Ethionamide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Ethionamide—Vomiting—Mycophenolic acid—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Ethionamide—Rash—Mycophenolic acid—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Ethionamide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Ethionamide—Hepatitis—Methotrexate—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Ethionamide—Headache—Mycophenolic acid—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Ethionamide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Ethionamide—Nausea—Leflunomide—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Ethionamide—Vision blurred—Prednisone—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Ethionamide—Diarrhoea—Lisinopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Ethionamide—Agitation—Prednisone—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Ethionamide—Dizziness—Lisinopril—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Ethionamide—Nausea—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Ethionamide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Ethionamide—Vomiting—Lisinopril—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Ethionamide—Rash—Lisinopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Ethionamide—Dermatitis—Lisinopril—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Ethionamide—Headache—Lisinopril—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Ethionamide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Ethionamide—Dysgeusia—Methotrexate—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Ethionamide—Nausea—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Ethionamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Ethionamide—Vision blurred—Methotrexate—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Ethionamide—Anorexia—Prednisone—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Ethionamide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Ethionamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Ethionamide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Ethionamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Ethionamide—Dyspepsia—Prednisone—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Ethionamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Ethionamide—Decreased appetite—Prednisone—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Ethionamide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Ethionamide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Ethionamide—Anorexia—Methotrexate—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Ethionamide—Abdominal pain—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Ethionamide—Somnolence—Methotrexate—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Ethionamide—Hypersensitivity—Prednisone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Ethionamide—Dyspepsia—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Ethionamide—Decreased appetite—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Ethionamide—Diarrhoea—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Ethionamide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Ethionamide—Dizziness—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Ethionamide—Abdominal pain—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Ethionamide—Vomiting—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Ethionamide—Rash—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Ethionamide—Dermatitis—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Ethionamide—Headache—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Ethionamide—Hypersensitivity—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Ethionamide—Nausea—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Ethionamide—Diarrhoea—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Ethionamide—Dizziness—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Ethionamide—Vomiting—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Ethionamide—Rash—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Ethionamide—Dermatitis—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Ethionamide—Headache—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ethionamide—Nausea—Methotrexate—systemic scleroderma	0.00098	0.00098	CcSEcCtD
